Europe Coronary Stents Market By Product type (Drug-eluting stents - Polymer Based Coatings, Polymer Free Coatings; Bare-Metal Stents; Bioresorbable Vascular Scaffold)

Europe Coronary Stents Market By Product type (Drug-eluting stents - Polymer Based Coatings, Polymer Free Coatings; Bare-Metal Stents; Bioresorbable Vascular Scaffold)

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Date of Publication -20-11-2018 | Number of Pages - 79 | Format - PDF

Chapter 1.    Market Scope & Methodology
1.1    Market Definition
1.2    Objectives
1.3    Market Scope
1.4    Segmentation
1.4.1    Europe Coronary Stents Market, by Product type
1.4.2    Europe Coronary Stents Market, by Country
1.5    Methodology for the research
Chapter 2.    Market Overview
2.1    Introduction
2.1.1    Overview
2.1.2    Market Composition and Scenario
2.1.3    Players Outlook for the Market
2.2    Key Factors Impacting the Market
2.2.1    Market Drivers
2.2.2    Market Restraints
Chapter 3.    Europe Coronary Stents Market by Product Type
3.1.1    Europe Drug-eluting stents (DES) Market by Country
3.1.2    Europe Coronary Stents Market by Drug-eluting stents (DES) Type
3.1.2.1    Europe Polymer Based Coatings Market by Country
3.1.2.2    Europe Polymer Free Coatings Market by Country
3.1.2.3    Europe Coronary Stents Market by Polymer Free Drug Eluting Stents Type
3.1.2.3.1    Europe Micro Structured Surface Market by Country
3.1.2.3.2    Europe Micro porous Surface Market by Country
3.1.2.3.3    Europe Slotted Tubular Surface Market by Country
3.1.2.3.4    Europe Nanoporous Surface Market by Country
3.1.3    Europe Bare-Metal Stents Market by Country
3.1.4    Europe Bioresorbable Vascular Scaffold Market by Country
Chapter 4.    Europe Coronary Stents Market by Country
4.1    Germany Coronary Stents Market
4.1.1    Germany Coronary Stents Market by Product Type
4.1.1.1    Germany Coronary Stents Market by Drug-eluting stents (DES) Type
4.1.1.1.1    Germany Coronary Stents Market by Polymer Free Drug Eluting Stents Type
4.2    UK Coronary Stents Market
4.2.1    UK Coronary Stents Market by Product Type
4.2.1.1    UK Coronary Stents Market by Drug-eluting stents (DES) Type
4.2.1.1.1    UK Coronary Stents Market by Polymer Free Drug Eluting Stents Type
4.3    France Coronary Stents Market
4.3.1    France Coronary Stents Market by Product Type
4.3.1.1    France Coronary Stents Market by Drug-eluting stents (DES) Type
4.3.1.1.1    France Coronary Stents Market by Polymer Free Drug Eluting Stents Type
4.4    Russia Coronary Stents Market
4.4.1    Russia Coronary Stents Market by Product Type
4.4.1.1    Russia Coronary Stents Market by Drug-eluting stents (DES) Type
4.4.1.1.1    Russia Coronary Stents Market by Polymer Free Drug Eluting Stents Type
4.5    Spain Coronary Stents Market
4.5.1    Spain Coronary Stents Market by Product Type
4.5.1.1    Spain Coronary Stents Market by Drug-eluting stents (DES) Type
4.5.1.1.1    Spain Coronary Stents Market by Polymer Free Drug Eluting Stents Type
4.6    Italy Coronary Stents Market
4.6.1    Italy Coronary Stents Market by Product Type
4.6.1.1    Italy Coronary Stents Market by Drug-eluting stents (DES) Type
4.6.1.1.1    Italy Coronary Stents Market by Polymer Free Drug Eluting Stents Type
4.7    Rest of Europe Coronary Stents Market
4.7.1    Rest of Europe Coronary Stents Market by Product Type
4.7.1.1    Rest of Europe Coronary Stents Market by Drug-eluting stents (DES) Type
4.7.1.1.1    Rest of Europe Coronary Stents Market by Polymer Free Drug Eluting Stents Type
Chapter 5.    Company Profiles
5.1    ABBOTT LABORATORIES
5.1.1    Company Overview
5.1.2    Financial Analysis
5.1.3    Regional & Segmental Analysis
5.1.4    Research & Development Expense
5.2    Terumo Medical Corporation
5.2.1    Company Overview
5.2.2    Financial Analysis
5.2.3    Segmental and Regional Analysis
5.2.4    Research & Development Expense
5.3    Medtronic Plc.
5.3.1    Company Overview
5.3.2    Financial Analysis
5.3.3    Segmental and Regional Analysis
5.3.4    Research & Development Expense
5.4    B. Braun Melsungen AG.
5.4.1    Company Overview
5.4.2    Financial Analysis
5.4.3    Segmental Analysis
5.4.4    Research & Development Expense
5.5    Boston Scientific Corporation
5.5.1    Company Overview
5.5.2    Financial Analysis
5.5.3    Segmental and Regional Analysis
5.5.4    Research & Development Expense
5.6    C.R. Bard, Inc.
5.6.1    Company Overview
5.6.2    Financial Analysis
5.6.3    Segmental and Regional Analysis
5.6.4    Research & Development Expense
5.7    Cook Group Incorporated
5.7.1    Company Overview
5.8    Johnsons & Johnsons
5.8.1    Company Overview
5.8.2    Financial Analysis
5.8.3    Segmental Analysis
5.8.4    Regional Analysis
5.8.5    Research & Development Expense
5.9    BIOTRONIK SE & CO. KG
5.9.1    Company Overview
5.1    Biosensors International Group Ltd.
5.10.1    Company Overview


Share



Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities